Skip to main content
Clinical Trials/CTRI/2022/08/044729
CTRI/2022/08/044729CompletedPhase 2

To evaluate the clinical efficacy of Trikatu and Haridra churna in the management of Medodushti(Dyslipidemia)

Institute of Medical Sciences0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients between age group of 25 â?? 60 years in either sex.
  • Diagnosed and confirmed cases of Dyslipidemia (Medodushti) on the basis of criteria given by NCEP ATP III
  • Newly diagnosed case of NIDDM with optimal control Diabetes mellitus

Exclusion Criteria

  • Patients with age below 25 year and above 60 years.
  • Patients have medical history of unstable angina, myocardial infarction, heart failure, stroke within 3 months of study, stage 2hypertension,stage 3 hypertension,type I diabetes mellitus, impaired renal function, hypothyroidism, jaundice, hepatitis, chronic infection and other serious diseases.
  • Pregnancy, lactation and patients having dyslipidemia due to drugs ex. Glucocorticoids, diuretics.
  • BMI >30Kg/m2
  • Patients not giving consent.

Investigators

Sponsor
Institute of Medical Sciences

Similar Trials